Search

The article discusses the development of a gel-based oral drug delivery system for controlled dosing of small molecules in mice, specifically targeting microglia depletion and inducible Cre recombination. The system allows for controlled consumption and dosage adjustment of water-insoluble small molecules like PLX5622 and Tamoxifen, offering a less invasive alternative to traditional application methods. The study demonstrates high efficacy rates for microglia depletion and inducible Cre recombination using the gel-based drug delivery system, showing promise for future research applications in mouse studies. [Extracted from the article]

Researchers from Parul University in Vadodara, India, have conducted a study on the potential of nanotherapeutics in enhancing drug delivery for neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's. The study emphasizes the importance of leveraging nanomedicine to improve drug solubility, circulation time, and targeted delivery while minimizing off-target effects. The findings highlight the need for innovative therapeutic strategies to address the challenges posed by neurodegenerative diseases on individuals and healthcare systems. [Extracted from the article]

A recent study conducted at Daegu Catholic University in South Korea focused on establishing an optimal drug delivery system using a hydrogel contact lens with Tretinoin and protein nanoparticles. The research aimed to improve ophthalmic drug delivery systems by analyzing the physical properties of the manufactured lens, including wettability, tensile strength, and drug release. The study found that the contact lens containing Tretinoin and bovine serum albumin using the soak and release method showed superior results compared to other methods, suggesting potential for various applications in ophthalmic medicine. For more information, the full article can be accessed through Polymers journal. [Extracted from the article]

Researchers from the Technical University of Denmark (DTU) have published a study on prodrugs and their activation mechanisms for brain drug delivery. Prodrugs are designed to improve drug properties and increase site specificity by becoming pharmacologically active after a structural change in the body. The research highlights the importance of the prodrug approach in developing brain-targeting drugs due to brain barriers limiting entry of certain drug entities. This peer-reviewed study reviews tools developed since 2000 for central nervous system (CNS) prodrug activation, aiming to contribute to innovative discoveries in brain drug development. [Extracted from the article]

Researchers at the University of Macau have published a study on the progress of supramolecular drug delivery nanosystems based on polyphenols. These nanosystems have shown promise in delivering drugs effectively due to their controllable drug-releasing properties and simple preparation techniques. The study highlights the potential of polyphenols in defending against various health issues and broadening the scope of biomedical applications. The research aims to provide insights into the design and study of polyphenol-based materials for drug delivery systems. [Extracted from the article]

A study conducted at Ocean University of China focused on developing a drug delivery system for the treatment of ischemic stroke using traditional Chinese medicine. The research involved the use of borneol-based polymeric micelles to deliver neuroprotective agents to the brain, effectively reducing cerebral infarction and improving neurological function. The findings suggest a potential treatment strategy for clinical ischemic stroke, highlighting the benefits of integrating traditional Chinese medicine with modern drug delivery systems. [Extracted from the article]

Researchers at Zhejiang University of Technology in Huzhou, China, have developed a novel drug delivery carrier called CS-HM@CMCNa, which is a core-shell hydrogel with super absorption and long-term acid resistance stability. This new material addresses the challenge of maintaining drug stability in the harsh gastric environment, offering potential benefits for sustained-release systems in treating chronic diseases. Funded by various organizations, this research has been peer-reviewed and published in the Journal of Materials Chemistry B. For more information, readers can contact the lead author, Si Chen, at Zhejiang University of Technology in China. [Extracted from the article]

Researchers from Fatih Sultan Mehmet Vakif University in Istanbul, Turkey, have focused on advancements in drug targeting, drug delivery, and nanotechnology applications for cancer treatment. The study emphasizes the importance of drug targeting to ensure drugs act only in the affected area, with a specific focus on cancer treatment. The research discusses various drug delivery systems, including nanocarrier-based methods, and highlights the significance of combining nanoparticle technologies to effectively treat cancer at both local and systemic levels. The study also explores drug carrier systems in nanobiotechnology and provides insights into market research on commercial drugs used in cancer nanotechnological approaches. [Extracted from the article]

A recent report from the Ministry of Health in Baghdad, Iraq, discusses the use of nano vesicles as a promising drug delivery system for treating degenerative diseases, cancer, and inflammation. The research emphasizes the importance of accurately characterizing nanocarriers to control particle size, surface characteristics, and drug release for specific therapeutic goals. Various sophisticated microscopic methods such as electron microscopy and dynamic light scattering are used to assess the size, structure, and charged state of nanocarriers. For more information, readers can access the full article in the Journal of Emergency Medicine, Trauma and Acute Care. [Extracted from the article]

University of Mississippi researchers have conducted a comprehensive review on Self-Emulsifying Drug Delivery Systems (SEDDS) in personalized medicine. The study highlights the advancements and applications of SEDDS, focusing on their transition from liquid to solid forms to improve drug solubility and bioavailability. The researchers emphasize the potential of SEDDS in revolutionizing drug delivery, offering enhanced stability, scalability, and patient compliance, with innovations such as 3D printing and targeted systems showing promise for diverse therapeutic applications. Despite challenges like scalability and excipient toxicity, emerging technologies and collaborations are paving the way for next-generation SEDDS in modern pharmaceutical development. [Extracted from the article]

A study conducted at Henan University in Luoyang, People's Republic of China, focused on the development of a cyclodextrin-grafted-chitosan thermosensitive hydrogel using dual gelling agents for drug delivery and antibacterial materials. The hydrogel demonstrated good temperature sensitivity, injectability, and sustained release effect, with high biocompatibility and biosafety. The research concluded that the hydrogel has promising applications in drug delivery and antibacterial fields, inhibiting the activity of Escherichia coli and Staphylococcus aureus. The study was supported by the Natural Science Foundation of Henan Province and the National Natural Science Foundation of China. [Extracted from the article]

Researchers at the University of Strathclyde have conducted a study on the use of silk fibroin in drug delivery systems. They have developed a method called elliptical vibration micro-turning to produce silk fibroin particles for drug carriers. The study found that this method can create shorter, spiral-shaped chips that are more effective for drug delivery compared to traditional methods. This research offers a new approach to fabricating silk fibroin particles with high potential for enhancing drug-loading efficiency in precision drug delivery systems. [Extracted from the article]

Researchers at the University College London (UCL) School of Pharmacy have developed temperature-responsive nanofibers for anticancer drug delivery. The nanofibers, loaded with ferulic acid as a model drug, showed sustained release of the drug with different profiles at varying temperatures. The study concluded that these nanofibers could potentially be used in developing implantable devices for cancer treatment. The research was supported by the Ministry of Finance Republic of Indonesia and published in Next Materials. [Extracted from the article]

Researchers at the School of Bioengineering in Tamil Nadu, India, have developed a drug delivery formulation using depolymerized hyaluronic acid conjugated with poly(lactic-co-glycolic acid) nanoparticles to enhance the therapeutic efficacy of prednisolone while minimizing side effects. The nanoparticles were prepared and characterized for size, morphology, drug-loading efficiency, and drug release kinetics, showing promising results. The study concludes that these nanoparticles could be effective drug carriers for biomedical applications, as demonstrated in in vitro assays. Financial support for the research came from the SRM Institute of Science and Technology in India. [Extracted from the article]

Researchers at Beijing University of Chemical Technology have conducted a study on drug delivery systems, focusing on the preparation of poly(disulfide)s. The study highlights the environmental sensitivity of poly(disulfide)s, making them valuable in drug delivery applications. The research reviews ring-opening polymerization strategies for disulfides and discusses their use in nucleic acid, protein, and small molecule drug delivery. The findings have been peer-reviewed and offer insights into the potential applications of poly(disulfide)s in drug delivery. [Extracted from the article]

Researchers at Nazarbayev University in Astana, Kazakhstan, have explored the use of doxorubicin-conjugated nanoparticles as potential drug delivery systems. Doxorubicin is a commonly used chemotherapy drug with side effects, and nanoparticles could offer targeted delivery to increase treatment efficiency and reduce side effects. The study discusses different methods of conjugating doxorubicin to nanoparticles and their potential benefits, focusing on metallic, silica/organosilica, and polymeric nanoparticles. This research provides valuable insights into the development of novel drug delivery systems. [Extracted from the article]

Researchers at Catholic University in Temuco, Chile, conducted a study on the release of methylene blue from nanocellulose/nanoporous silicon composites, which are potential drug delivery systems. The study developed a finite element method to model diffusion and drug release processes, showing that the nanoporous silicon concentration significantly affects release control. The findings suggest that this method can be applied to model other complex systems, leading to advancements in precision drug delivery and broader biomedical applications. For more information, the full article is available in Pharmaceutics, and the researchers involved can be contacted for additional details. [Extracted from the article]

The University of Salerno conducted a study on using the prilling technique to produce nano- and submicrometric PLGA particles for controlled drug delivery, focusing on curcumin as the model drug. The research optimized key process parameters to achieve stable particles with high encapsulation efficiency and controlled release profiles. The study concluded that this technique has potential for biomedical applications, offering a versatile platform for designing drug delivery systems with tailored release characteristics. [Extracted from the article]

A recent study conducted at the National Research Centre in Giza, Egypt, focused on the treatment of hyperhidrosis, a condition characterized by excessive sweating. The study compared the effectiveness of fractional laser-assisted drug delivery of botulinum toxin versus traditional botulinum toxin injections in patients with primary palmar and axillary hyperhidrosis. Results showed a significant decrease in disease severity and improvement in quality of life for patients in both treatment groups. The research concluded that fractional CO2 laser-assisted drug delivery is a safe and minimally invasive procedure that enhances the delivery of botulinum toxin. [Extracted from the article]

Researchers at Goethe-University Frankfurt in Germany have developed a disease-adaptive nanocarrier system for the treatment of inflammatory bowel disease (IBD). This system allows for pH-dependent drug release in IBD-affected tissue, with drug release rates varying based on the pH levels in the tissue. The study highlights the potential of disease-adaptive drug delivery for treating inflammatory diseases and emphasizes the impact of biocorona formation on therapeutic effectiveness in the gastrointestinal tract. The research was funded by Deutsche Forschungsgemeinschaft and Bundesministerium fur Bildung und Forschung, and the findings were published in Advanced Therapeutics. [Extracted from the article]

Researchers at the Department of Periodontology conducted a study comparing the drug release kinetics of Terminalia arjuna mediated selenium nanoparticles (SeNPs) gel and zinc oxide nanoparticles (ZnONPs) gel for potential use in local drug delivery for chronic periodontitis. The investigation found that SeNPs gel exhibited higher drug release percentages compared to ZnONPs gel, with sustained release profiles suggesting effective control over drug release. The study concluded that Terminalia arjuna mediated SeNPs gel shows promise for more rapid and sustained drug delivery in managing chronic periodontitis through local drug delivery systems. [Extracted from the article]

Researchers at the University of West London have developed a collagen-based micro-implant using 3D bioprinting technology to address challenges in treating retinal diseases like age-related macular degeneration and diabetic retinopathy. The implant allows for sustained and localized drug delivery, overcoming the need for frequent injections and increasing patient compliance. This innovative approach has the potential to revolutionize drug delivery and localized tissue therapy for retinal diseases, offering slow drug release and scaffold stability for over 80 days. [Extracted from the article]

Research from Visva-Bharati University focuses on modeling hollow microneedle-mediated drug delivery in the skin, specifically considering drug binding. The study explores the transport of verapamil in the skin and its absorption in blood and tissue compartments, taking into account factors like reversible binding and interstitial flow. The findings suggest that factors such as tip diameter and injection velocity play crucial roles in the effectiveness of microneedle therapy, highlighting the importance of understanding drug delivery mechanisms for improved treatment outcomes. [Extracted from the article]

Researchers from Nankai University in Tianjin, China, have developed a multistage drug delivery system for enhanced subacute ischemic stroke treatment. The system utilizes calixarene to load the neuroprotective drug simvastatin, targeting the blood-brain barrier and inflammatory responses. In a rat model, the system improved motor function and repaired brain damage post-stroke, offering a promising strategy for stroke patients beyond the acute therapy window. This research was supported by various funding sources and has been peer-reviewed, providing a multi-level treatment approach for stroke recovery. [Extracted from the article]

A study conducted at Gujarat Technology University in India focused on developing a solid self-nanoemulsifying drug delivery system (S-SNEDDS) for Fimasartan Potassium Trihydrate (FPT), an antihypertensive agent with poor water solubility. The optimized formulation showed enhanced solubility, dissolution, bioavailability, and stability of the drug compared to conventional dosage forms. The research demonstrated a significant increase in drug dissolution rate, improved bioavailability, and stability over a six-month period, suggesting the potential use of S-SNEDDS for delivering FPT effectively. [Extracted from the article]

Researchers from Lovely Professional University have developed a self-emulsifying drug delivery system (SNEDDS) for chrysin, a herbal drug tested for treating Alzheimer's disease. The SNEDDS showed significantly higher bioavailability than regular chrysin and improved cognitive functions in AD-induced rats. The study concluded that chrysin SNEDDS loaded reduced levels of AChE enzyme, amyloid b, oxidative stress, and neuroinflammation. This research provides insights into potential advancements in Alzheimer's disease treatment. [Extracted from the article]

A patent has been issued to Ansella Therapeutics Inc. for compositions and methods aimed at preventing and treating various conditions, particularly focusing on vulvovaginal health. The patent outlines formulations designed to provide lubricity, protect skin and tissues, and facilitate drug delivery. These compositions are intended to offer relief from vulvovaginal symptoms, treat underlying pathophysiology or infections, and prophylactically protect the vulvovaginal anatomy. The patent emphasizes the need for effective and safe products in this area of healthcare. [Extracted from the article]

Dose Medical Corporation has been issued a patent for a drug-eluting ocular implant designed to treat ocular disorders by providing targeted drug delivery to intraocular tissues. The patent outlines methods for treating increased intraocular pressure and various ocular diseases using surgically implanted drug delivery devices. The invention aims to address challenges in administering therapeutic agents to the eye effectively and efficiently, offering a controlled and targeted approach to drug delivery. [Extracted from the article]

A patent has been issued for an ingestible drug delivery device configured for wireless communication, developed by Pop Test Abuse Deterrent Technology LLC. The device includes sensors, bioactive substance modules, electronics modules, and a power source, allowing for wireless signal transmission and reception between devices. This invention aims to enhance drug delivery systems and prevent drug poisoning by enabling controlled dispensing of bioactive substances based on specific conditions and verifications. [Extracted from the article]

The patent issued for a spacer assembly for a drug delivery device by Becton Dickinson and Company focuses on a drive assembly for a drug delivery system that includes a plunger member, a biasing member, and an adjustable spacer assembly. The spacer assembly allows for modification of the axial length of the assembly by a predetermined distance. The invention aims to improve drug delivery systems by providing a mechanism for gradually injecting a liquid therapeutic preparation into a patient's skin. [Extracted from the article]

A patent has been issued for porous structures designed for extended release drug delivery devices by ForSight Vision4 Inc. The invention aims to address limitations of existing drug delivery systems by providing improved therapeutic devices that ensure sustained release of therapeutic agents over an extended period. The patented device includes a refillable reservoir, a porous structure made of sintered material, and a barrier layer to control the diffusion rate of the therapeutic agent and block contaminants from entering the eye or reservoir. This innovation offers a promising solution for enhancing drug delivery efficiency and patient safety in medical treatments. [Extracted from the article]

The patent issued for a drug-eluting ocular implant by Dose Medical Corporation aims to provide targeted and controlled drug release for the treatment of ocular diseases. The implant is designed to address difficulties in administering therapeutic agents to the eye effectively and efficiently. By allowing for controlled and targeted drug delivery, this innovation seeks to improve treatment outcomes and reduce side effects associated with current delivery methods. [Extracted from the article]

A patent application by inventors Finkelstein and Jensen, assigned to Amgen Inc., outlines a method for manufacturing a plunger for drug delivery devices. The process involves stamping sheet metal to create plunger bodies, loading them into a molding tool, and injecting molten plastic to form an overmolded plunger body. The application aims to address challenges in drug delivery systems by providing alternatives to existing devices. This innovative approach offers flexibility in spring design and facilitates the use of springs with different physical characteristics. [Extracted from the article]

The patent application by Florian Schauderna focuses on drug delivery devices with pressure sensors to monitor the quality of drug delivery operations. The electronics assembly in the device can detect pressure changes during drug delivery, calculate the amount of medicament delivered, and provide alerts to users based on the sensed pressure. This innovation aims to improve the accuracy and reliability of drug delivery, especially for conditions like diabetes that require frequent injections. The application also discusses the potential use of wireless connectivity and additional features to enhance the functionality of the drug delivery devices. [Extracted from the article]

Amgen Inc. has been issued a patent for a drug delivery device that aims to improve the effectiveness and safety of drug delivery methods. The device is designed to provide precise and reliable parenteral drug delivery, bypassing the digestive system to ensure the drug reaches the intended site at a significant concentration. The patent outlines the components and mechanisms of the wearable drug delivery device, emphasizing its potential benefits for patients and healthcare providers. This innovation addresses the need for cost-efficient, easy-to-use drug delivery devices with integrated safety features, catering to the market demand for improved medical treatments. [Extracted from the article]

A patent has been issued for a cartridge assembly for a drug delivery device by Sanofi, focusing on improving drug delivery systems. The invention aims to prevent errors in drug cartridge insertion, enhance cartridge durability, and ensure compatibility with various drug dimensions. The patent details the design of the cartridge assembly, including features like a fixing surface to secure the cartridge and a cartridge guiding feature for radial movement. This innovation addresses safety concerns and efficiency in drug delivery devices. [Extracted from the article]

A recent study from Yeungnam University in South Korea explores the use of biodegradable and stimuli-responsive nanomaterials for targeted drug delivery in autoimmune diseases. These nanomaterials are designed to release therapeutic agents in response to specific stimuli, minimizing systemic toxicity and enhancing therapeutic efficacy. The research highlights the potential of these advanced nanotechnologies to improve patient outcomes in autoimmune disease management. For more information, the full article can be accessed for free at https://doi.org/10.3390/jfb16010024. [Extracted from the article]

A recent study from Nankai University explores the challenges of treating brain diseases due to the blood-brain barrier's restrictive nature. The research focuses on targeting brain drug delivery with macromolecules through receptor-mediated transcytosis (RMT) as a promising approach. The study highlights the potential of RMT-based strategies to revolutionize therapy for brain diseases, emphasizing the use of natural ligands and macromolecular delivery systems. This comprehensive overview discusses advancements in drug delivery systems and emerging RMT strategies for precision in brain-targeted treatments. [Extracted from the article]

Researchers at the Indian Institute of Technology in Kharagpur, India, have developed electrically conductive hydrogels for on-demand drug delivery in tissue engineering. These hydrogels have shown promise in enhancing the therapeutic efficacy of biomolecules through higher loading of therapeutic cargo with on-demand delivery. The study explores the properties, mechanisms, fabrication techniques, and recent advancements of these electrically responsive 'SMART' systems for potential clinical applications. Funded by the Ministry of Education in India, this research highlights the potential of electrically conductive hydrogels in improving drug delivery systems. [Extracted from the article]

Researchers at the Ministry of Education in Harbin, China, have developed a new nano drug delivery system targeting lung cancer using Platycodon grandiflorus. The system aims to enhance the efficiency of delivering Paclitaxel and improve anti-tumor efficacy. The study concluded that this lung-targeted system could enhance the therapeutic effect of chemotherapy drugs on lung cancer. For more information, the research article can be accessed for free at the publisher's website. [Extracted from the article]

A recent report from Jilin University discusses the use of zeolitic imidazolate frameworks (ZIFs) as drug delivery systems for cancer therapy. ZIFs, a subtype of metal-organic frameworks, have shown promise in the field of biomaterials due to their flexibility, stability, and controllability. The review highlights the structures, synthesis methods, properties, and modifiers of ZIFs used in cancer treatment, as well as recent advancements in their application as tumor treatments. The researchers aim to further explore the potential of ZIF-based materials for effective cancer treatment and early clinical application. [Extracted from the article]

A recent study conducted at Shanxi Provincial People's Hospital in the People's Republic of China focused on utilizing aluminum nitride nanoparticles for drug delivery, specifically for metformin in lung cancer treatment. The research highlighted the effectiveness of the nanostructure in encapsulating metformin and releasing it selectively in response to varying pH levels. The study concluded that this bioavailable drug delivery system could potentially reduce off-target effects and toxicity associated with conventional therapies. For more information, readers can refer to the article "Experimental and Theoretical Study of Delivering Metformin Anti-lung Cancer Drug With Aluminum Nitride Nanoparticles" published in Applied Organometallic Chemistry. [Extracted from the article]

Researchers at Jilin University have published a new study on colon cancer, focusing on the use of multifunctional drug delivery nanoparticles for combined chemotherapy/chemodynamic/photothermal therapy. The study highlights the development of intelligent nanoparticles that enhance the anti-tumor efficacy of chemotherapeutic agents through various therapeutic capabilities. This innovative strategy aims to combat colorectal cancer effectively by inducing cuproptosis/ferroptosis/apoptosis to inhibit tumor growth. The research provides valuable insights into the potential of combining different modes of therapy for cancer treatment. [Extracted from the article]

A recent report from Chongqing University in the People's Republic of China discusses the challenges in cancer treatment and the potential of precision antitumor medicine using supramolecular drug-delivery nanosystems. The research highlights the importance of targeted drug delivery to improve efficacy and reduce side effects in cancer therapy. The study reviews the progress in constructing supramolecular nanostructures, controlled drug release strategies, and the biological applications of supramolecular drug delivery nanosystems for cancer treatment. The research, supported by the National Natural Science Foundation of China, emphasizes the potential and key challenges of using supramolecular drug delivery nanotechnology for precision cancer therapy. [Extracted from the article]

A patent has been issued for clotting factor preparations that can be delivered into the tissue of the intestinal tract using a swallowable drug delivery device. This innovation aims to provide an alternative method for delivering clotting factors such as Factor VIII, which are traditionally administered through injections. The technology is designed to address limitations and challenges associated with current forms of hemophilia treatments, including the development of antibodies that can reduce the effectiveness of clotting factors. [Extracted from the article]

A recent study conducted by researchers at University College Dublin explores the use of cold plasma deposition of the drug Topotecan for local drug delivery to glioblastoma cells. Glioblastoma multiforme (GBM) is a highly aggressive form of brain cancer with limited treatment options, making the development of new therapeutic strategies crucial. The study found that the combination of plasma-based technologies and Topotecan showed enhanced cytotoxic effects on human brain cancer cells, suggesting a potential new approach for local cancer drug application. This research opens up possibilities for novel combinations and approaches to local drug delivery for various types of cancers. [Extracted from the article]